On the stock market since 2015, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
Average growth of 6% a year over the last 4 years. Red columns mark years that ended in a loss.
The stock trades 32% below its peak. The market has trimmed its expectations for the company.
Sales run at $9.1M a year. A small number, but proof the product has real buyers.
It pays out $0.55 per share each year — regular cash for whoever holds the stock.
A loss of $121.2M against $9.1M in annual sales.
Since the drop from its peak, buyer appetite hasn’t come back.
On our five-subject report card, BXEAX sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: BXEAX is a high-risk stock — not yet profitable, and its future rides on its product catching on.